Immunogenetics of type 1 diabetes: A comprehensive review
- PMID: 26272854
- DOI: 10.1016/j.jaut.2015.07.014
Immunogenetics of type 1 diabetes: A comprehensive review
Abstract
Type 1 diabetes (T1D) results from the autoimmune destruction of insulin-producing beta cells in the pancreas. Prevention of T1D will require the ability to detect and modulate the autoimmune process before the clinical onset of disease. Genetic screening is a logical first step in identification of future patients to test prevention strategies. Susceptibility to T1D includes a strong genetic component, with the strongest risk attributable to genes that encode the classical Human Leukocyte Antigens (HLA). Other genetic loci, both immune and non-immune genes, contribute to T1D risk; however, the results of decades of small and large genetic linkage and association studies show clearly that the HLA genes confer the most disease risk and protection and can be used as part of a prediction strategy for T1D. Current predictive genetic models, based on HLA and other susceptibility loci, are effective in identifying the highest-risk individuals in populations of European descent. These models generally include screening for the HLA haplotypes "DR3" and "DR4." However, genetic variation among racial and ethnic groups reduces the predictive value of current models that are based on low resolution HLA genotyping. Not all DR3 and DR4 haplotypes are high T1D risk; some versions, rare in Europeans but high frequency in other populations, are even T1D protective. More information is needed to create predictive models for non-European populations. Comparative studies among different populations are needed to complete the knowledge base for the genetics of T1D risk to enable the eventual development of screening and intervention strategies applicable to all individuals, tailored to their individual genetic background. This review summarizes the current understanding of the genetic basis of T1D susceptibility, focusing on genes of the immune system, with particular emphasis on the HLA genes.
Keywords: Disease association; HLA; KIR; Polymorphism; Prevention; Type 1 diabetes.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
HLA and autoimmune diseases: Type 1 diabetes (T1D) as an example.Autoimmun Rev. 2006 Mar;5(3):187-94. doi: 10.1016/j.autrev.2005.06.002. Epub 2005 Aug 1. Autoimmun Rev. 2006. PMID: 16483918 Review.
-
Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.BMC Genomics. 2005 Apr 20;6:56. doi: 10.1186/1471-2164-6-56. BMC Genomics. 2005. PMID: 15842729 Free PMC article.
-
14th International HLA and Immunogenetics Workshop: report on the HLA component of type 1 diabetes.Tissue Antigens. 2007 Apr;69 Suppl 1:214-25. doi: 10.1111/j.1399-0039.2006.00772.x. Tissue Antigens. 2007. PMID: 17445204 Review.
-
Prediction of the risk of type 1 diabetes from polymorphisms in candidate genes.Diabetes Res Clin Pract. 2004 Dec;66 Suppl 1:S19-25. doi: 10.1016/j.diabres.2003.10.026. Diabetes Res Clin Pract. 2004. PMID: 15563974 Review.
-
Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism.J Hum Genet. 2015 Nov;60(11):697-702. doi: 10.1038/jhg.2015.100. Epub 2015 Aug 20. J Hum Genet. 2015. PMID: 26290149 Review.
Cited by
-
Activation pathways that drive CD4+ T cells to break tolerance in autoimmune diseases.Immunol Rev. 2022 May;307(1):161-190. doi: 10.1111/imr.13071. Epub 2022 Feb 10. Immunol Rev. 2022. PMID: 35142369 Free PMC article. Review.
-
The immunopathogenesis of narcolepsy type 1.Nat Rev Immunol. 2024 Jan;24(1):33-48. doi: 10.1038/s41577-023-00902-9. Epub 2023 Jul 3. Nat Rev Immunol. 2024. PMID: 37400646 Review.
-
Systemic lupus erythematosus and pulmonary tuberculosis in a patient developing acute-onset type 1 diabetes.Diabetol Int. 2024 Nov 12;16(1):175-181. doi: 10.1007/s13340-024-00772-z. eCollection 2025 Jan. Diabetol Int. 2024. PMID: 39877438
-
Association of serum 25-hydroxyvitamin D concentration with HLA-B, -DRB1 and -DQB1 genetic polymorphisms.Eur J Clin Nutr. 2017 Jan;71(1):128-131. doi: 10.1038/ejcn.2016.160. Epub 2016 Sep 14. Eur J Clin Nutr. 2017. PMID: 27623983
-
Familial aggregation and heritability of type 1 diabetes mellitus and coaggregation of chronic diseases in affected families.Clin Epidemiol. 2018 Oct 10;10:1447-1455. doi: 10.2147/CLEP.S172207. eCollection 2018. Clin Epidemiol. 2018. PMID: 30349392 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials